Advanced search
Publication Cover
Expert Review of Respiratory Medicine Volume 12, 2018 - Issue 6
Submit an article Journal homepage
2,076
Views
4
CrossRef citations to date
0
Altmetric
Drug Profile

An overview of glycopyrrolate/eFlow® CS in COPD

Edward KerwinClinical Research Institute of Southern Oregon, Inc., Medford, OR, USACorrespondence[email protected]
View further author information
&
Gary T. FergusonPulmonary Research Institute of Southeast Michigan, Farmington Hills, MI, USAView further author information
Pages 447-459 | Received 19 Apr 2018, Accepted 11 May 2018, Published online: 28 May 2018

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Donald P Tashkin, Ayca Ozol-Godfrey, Sanjay Sharma & Shahin Sanjar. (2021) Effect of SGRQ-Defined Chronic Bronchitis at Baseline on Treatment Outcomes in Patients with COPD Receiving Nebulized Glycopyrrolate. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 945-955.
Read now
James F Donohue, Ayca Ozol-Godfrey, Thomas Goodin & Shahin Sanjar. (2020) The Effect of Baseline Rescue Medication Use on Efficacy and Safety of Nebulized Glycopyrrolate Treatment in Patients with COPD from the GOLDEN 3 and 4 Studies. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 745-754.
Read now
Chitra Lal & Akram Khan. (2020) Emerging Treatments for COPD: Evidence to Date on Revefenacin. COPD: Journal of Chronic Obstructive Pulmonary Disease 17:1, pages 112-119.
Read now

Articles from other publishers (1)

Jill A. Ohar, Andrea Bauer, Sanjay Sharma & Shahin Sanjar. (2020) In Vitro Effect of Different Airflow Rates on the Aerosol Properties of Nebulized Glycopyrrolate in the eFlow® Closed System and Tiotropium Delivered in the HandiHaler®. Pulmonary Therapy 6:2, pages 289-301.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.